Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

NCT07232706 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

RSV Immunization

Interventions

DRUG: Nirsevimab
DRUG: Abrysvo

Sponsor

Centre Hospitalier Annecy Genevois